Vac003_s05_001

: The VAC-3S study is a Phase I/IIa dose-escalation trial evaluating a therapeutic vaccine in HIV-1 infected patients. Medical Procedures (Vacuum-Assisted Closure) :

: Studies like those for the CoVLP+AS03 vaccine often use "VAC" prefixes in trial registries to denote vaccine-specific safety and immunogenicity protocols. VAC003_s05_001

Based on the code structure, the "VAC003" prefix is most commonly associated with the following research areas: : : The VAC-3S study is a Phase I/IIa

The V-Dem Project uses alphanumeric codes to identify specific research papers and working papers (e.g., Working Paper 144). The "VAC" prefix in social sciences sometimes refers to or specific dataset segments. How to Access the Specific Paper VAC003_s05_001